Stay Away From Our Children
On 22 July 2021, the Therapeutics Goods Administration (TGA) granted “provisional approval” for the Pfizer vaccine in individuals 12 years and older. Provisional approval was previously granted for those over the age of 16.
According to the Australian Product Information (API), 2,260 adolescents 12 to 15 years of age were enrolled in the clinical trial (1,131 in the vaccine group and 1,129 in the placebo group). Of these teenagers, 1,308 (660 in the vaccine group and 648 in the placebo group) were followed for two months after their second dose.
The most frequent adverse reactions were “injection site pain (>90%), fatigue and headache (>70%), myalgia [muscle pain] and chills (>40%), arthralgia [joint pain] and pyrexia [fever] (>20%)”. All of these reactions were considered very common.
Common adverse reactions included nausea and injection site redness.
Uncommon reactions included lymphadenopathy [disease of the lymph nodes], insomnia [difficulty falling or staying asleep], decreased appetite, lethargy, hyperhidrosis [abnormal excessive sweating], night sweats, asthenia [abnormal physical weakness or lack of energy], and malaise [general feeling of discomfort, illness or unease].
Rare reactions included acute peripheral facial paralysis.
Adverse reactions from post-market experience include anaphylaxis, hypersensitivity reactions (e.g., rash, pruritis [itch], urticaria [hives], angioedema [swelling beneath the skin or mucosa]), myocarditis [inflammation of the heart muscle], pericarditis [inflammation of the heart membrane], diarrhoea, vomiting and arm pain.
To summarise the above findings, the majority of children had a reaction to a vaccine for a disease that is asymptomatic or mild in almost every case. It is completely illogical and irrational in every way possible to vaccinate children against COVID-19.
The Australian Public Assessment Report (AusPAR) states that the “adolescent group demonstrated increased frequency of headache, chills, and fever” in comparison to adult subjects. The report also claims that the “sample size is relatively small and is not sufficient for the detection of rare adverse reactions”.
Is it acceptable that children are placed at an increased risk of a reaction for a virus that they have no chance of dying from in Australia?
The AusPAR highlights further shortcomings. According to the report, the submitted data has the following limitations:
- The long-term efficacy and safety is not known.
- The VE (vaccine efficacy) against asymptomatic infection and viral transmission is not known.
- The number of adolescents in the study is not sufficient to detect very rare adverse events.
- No data available on the co-administration with quadrivalent seasonal influenza vaccine.
- Adolescents with immunodeficient status/high health risks are not specifically assessed.
- The VE (vaccine efficacy) against variants of concern has not been addressed.
The Joint Committee on Vaccination and Immunisation (JCVI) in the UK claims that “there are emerging reports from the UK and other countries of rare but serious adverse events, including myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane around the heart), following the use of Pfizer-BioNTech BNT162b2 and Moderna mRNA-1273 vaccines in younger adults… Data on the incidence of these events in children and young people are currently limited, and the longer-term health effects from the myocarditis events reported are not yet well understood.”
Myocarditis is a serious illness with long-term consequences. The cells of the heart do not regenerate. Once they are dead, they are dead. Why are we putting our children at risk of long-term heart damage?
“Until more data become available, JCVI does not currently advise routine universal vaccination of children and young people less than 18 years of age.”
“The health benefits in this population are small, and the benefits to the wider population are highly uncertain.”
“At this time, JCVI is of the view that the health benefits of universal vaccination in children and young people below the age of 18 years do not outweigh the potential risks.”
The health benefits in children do not outweigh the potential risks. Our government bureaucrats and health officials continually refuse to follow proper science. They need to be held accountable for putting our children at risk.
The JCVI clearly states that it the “evidence strongly indicates that almost all children and young people are at very low risk from COVID-19”.
“Where symptoms are seen in children and young people, they are typically mild, and little different from other mild respiratory viral infections which circulate each year.”
“The incidence of severe outcomes from COVID-19 in children and young people is extremely low.”
Are we trying to save children from a mild respiratory infection or are we trying to save them from dying?
“In England, between February 2020 and March 2021 inclusive, fewer than 30 persons aged less than 18 years died because of COVID-19, corresponding to a mortality rate of 2 deaths per million. During the second wave of the pandemic in the UK, the hospitalisation rate in children and young people was 100 to 400 per million. Most of those hospitalised had severe underlying health conditions.”
“For children and young people without underlying health conditions that put them at high risk of severe outcomes from COVID-19, the direct individual health benefits of COVID-19 vaccination are limited. While vaccination of younger cohorts could reduce the risk of outbreaks of COVID-19 in school settings, the vast majority of those infected in any outbreak will either be asymptomatic or have mild disease.”
The following statement by the JCVI is critical.
“At this time JCVI does not consider that the benefits of vaccination outweigh the potential risks. Until more safety data have accrued and their significance for children and young people has been more thoroughly evaluated, a precautionary approach is preferred.”
And what about ‘long COVID’?
“Concerns have been raised regarding post-acute COVID-19 syndrome (long COVID) in children. Emerging large-scale epidemiological studies indicate that this risk is very low in children, especially in comparison with adults, and similar to the sequelae of other respiratory viral infections in children.”
It could not be any clearer. Children are not at risk from the virus, and they should not be vaccinated against COVID-19.
In the US, there have been 14,494 adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) for those aged 12-17. Of the adverse events reported, there were 2,127 reports of anaphylaxis, 383 reports of myocarditis and pericarditis, and 68 reports of blood clotting disorders.
There have been 871 serious adverse events reported, along with 17 deaths.
At the time of writing, there has been 4,805 cases and zero deaths in people aged 0-19 in Australia since the beginning of the pandemic.
There is absolutely no justification for vaccinating children against COVID-19. Although they may contract the virus, in nearly all cases they will be asymptomatic or experience mild disease. The chance of developing long-COVID, severe illness, being hospitalised or dying is almost non-existent.
The clinical trials are not due for completion in 2023. Children are not guinea pigs and they are not to be experimented on. Ever.
We need to do everything we can to protect our children from government bureaucrats and health officials pushing an unproven and potentially dangerous vaccine.
It is time to stand up and unite. Share this widely and say no to vaccinating our kids.
Our children’s lives and our future generations depend on it.
